Manufacturer of medical equipment company intended to provide chronic pain relief devices. The company use monitoring and cutting-edge AI system will revolutionize the domain of chronic pain for both patients and healthcare professionals, enabling patients to give an advance and efficient pain relief medical equipment.

Convergence Partners is a pan-African tech focused private equity player, delivering enhanced investment returns while underpinning Continental development. We have a proven track record of developing new investment opportunities as well as active adding value to investments across the lifecycle of tech assets. As impact investors, Convergence Partners brings its skills, experience and capital to accelerate ICT infrastructure development in Africa, focusing on initiatives that increase availability of communications, broadband services and new technology offerings to the people of Africa

Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases. Its main offerings include pioneering scientific breakthroughs and expanding access to their medicines, with the ultimate goal of preventing and curing disease.

Atai Life Sciences is a biotechnology company that develops therapies for mental health disorders. The company focuses on creating treatments using psychedelic compounds and other methods to address conditions such as depression, anxiety, and substance use disorders. Atai collaborates with various partners and research institutions to advance its drug development pipeline, which includes several clinical-stage programs. The product portfolio includes therapies that utilize research in psychedelics and neuroscience. Atai's lead programs feature ketamine-based treatments and other compounds aimed at improving mental well-being. The company works with experts in the field to ensure the efficacy and safety of its therapies. Atai Life Sciences has received recognition for its work in mental health treatment, securing partnerships and funding to support its research initiatives. The company has been acknowledged for its contributions to psychiatry and has gained attention for its efforts to advance the understanding and treatment of mental health disorders.

Developer of a monitoring device designed to continuously track hormone levels in patients undergoing fertility treatments. The company's device monitors hormone levels directly from subcutaneous tissue to make informed treatment decisions, enabling healthcare providers to implement preventive measures before complications arise.

We build a SaaS platform that unlocks the power of medical data for everyone.

Growth debt for scale-up businesses. Take your next step to growth with Bootstrap Europe. We provide progressive, ambitious entrepreneurs and shareholders with non-dilutive funding to help them succeed.

Developer of a cold plasma technology designed to heal chronic wounds. The company's technology focuses on diabetic foot wounds, kills bacteria, stimulates cell proliferation, and improves microcirculation, enabling doctors to decrease the risk of amputation and increase the quality of life for patients.

We are a venture capital firm that invests in the best impact startups.